Louis Moore Bacon's CRL Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 10,903 shares of Charles River Laboratories International, Inc. (CRL) worth $2.17 M, representing 0.03% of the portfolio. First purchased in 2015-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in CRL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 27,438 shares. Largest reduction occurred in Q3 2015, reducing 65,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -38,022 | Reduce 77.71% | 10,903 | $199.48 |
| Q3 2025 | +22,116 | Add 82.49% | 48,925 | $156.46 |
| Q2 2025 | -15,116 | Reduce 36.05% | 26,809 | $151.73 |
| Q1 2025 | +27,438 | Add 189.40% | 41,925 | $150.52 |
| Q4 2024 | +14,487 | New Buy | 14,487 | $184.60 |
| Q3 2015 | -65,000 | Sold Out | 0 | $0.00 |
| Q2 2015 | +65,000 | New Buy | 65,000 | $70.34 |
Louis Moore Bacon's Charles River Laboratories International Investment FAQs
Louis Moore Bacon first purchased Charles River Laboratories International, Inc. (CRL) in Q2 2015, acquiring 65,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Charles River Laboratories International, Inc. (CRL) for 7 quarters since Q2 2015.
Louis Moore Bacon's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q2 2015, adding 65,000 shares worth $4.57 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 10,903 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $2.17 M.
As of the Q4 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.03% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Charles River Laboratories International, Inc. (CRL) was 65,000 shares, as reported at the end of Q2 2015.